Hide

FocusBar

Subscribe to Premium Member
Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M67.6Revenue $M0.1Net Margin (%)-13,278.4Z-Score0
Enterprise Value $M48.0EPS $-0.2Operating Margin %-13,376.3F-Score0
P/E(ttm))0Cash Flow Per Share $0Pre-tax Margin (%)-13,278.4Higher ROA y-yN
Price/Book010-y EBITDA Growth Rate %0Quick Ratio0Cash flow > EarningsN
Price/Sales2335-y EBITDA Growth Rate %0Current Ratio0Lower Leverage y-yN
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-230.3Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)0Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M159ROI % (ttm)0Gross Margin Increase y-yN

Gurus Latest Trades with RXII

Please Subscribe to see portfolio changes after the end of the last quarter. Real Time Picks are included for Premium Members only! Plans start from as little as $299/year.

7-Day FREE TRIAL
Number of guru portfolios checked: 51.

No Entry found!

RXII is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


RXII: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Galena Biopharma, Inc.10% Owner 2013-05-02Sell1,083,500$0.20view

Press Releases about RXII:

Quarterly/Annual Reports about RXII:

    News about RXII:

    Articles On GuruFocus.com
    RXi Pharmaceuticals Corp. (RXII) CEO Noah D Beerman buys 10,000 Shares Jul 12 2010 

    Add Notes, Comments or Ask Questions

    Comments

    No comment yet
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names
    Free 7-day Trial
    FEEDBACK